Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE004059

ID:

TCMBANKHE004059

植物拉丁名:

Resi oliani
显示图片

功能与主治:

1. To invigorate blood and stop pain; 2. To reduce swelling/Pain in heart and abdomen, wind-damp impediment pain, amenorrhea, dysmenorrhea, stasis pain from knocks and falls, swelling toxin of welling abscess and flat abscess, intestinal welling abscess, enduring sores.

药用植物名:

乳香

药用部位:

balsam

药味:

Warm; Pungent; Bitter

经络:

Spleen; Liver; Heart

临床特征:

1. Exerting significant analgesic effect.2. Dilating the peripheral blood vessels.3. Enhancing the phagocytosis of macrophages in the abdominal cavity of mice.

治疗类型:

活血祛瘀药

TCM_ID_id:

2834

SymMap_id:

341

TCMSP_id:

599

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN000023 acetyl-11-keto-β-boswellicacid acetyl 11-keto-β-boswellic acid C32H48O5
TCMBANKIN000100 lauric acid NCGC00090919-01; CHEBI:30805; n-Dodecanoic acid; Hydrofol acid 1255; Wecoline 1295; Neo-Fat 12-43; 8045-27-0; WLN: QV11; AI3-00112; AIDS-049202; 61609_FLUKA; Dodecylcarboxylate; DAO; EINECS 205-582-1; L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUROYL; CCRIS 669; W261408_ALDRICH; lauric acid ; 8000-62-2; DODECANOIC ACID (LAURIC ACID); C-1297; 7632-48-6; ST023796; NSC5026; Laurinsaeure; C02679; [2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM; Dodecoic acid; Laurostearic acid; NCGC00090919-02; 4-02-00-01082 (Beilstein Handbook Reference); lauricacid; Ninol AA62 extra; InChI=1/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14; Lauric acid (natural); Aliphat No. 4; NSC-5026; Coconut oil fatty acids; Lauric acid, pure; 203714-07-2; NCIOpen2_009480; CH3-[CH2]10-COOH; Dodecylic acid; Neo-Fat 12; AIDS049202; C12 fatty acid; HSDB 6814; Dodecanoic acid; L556_ALDRICH; Lauric acid; LAP; Univol U-314; FEMA No. 2614; 1-Undecanecarboxylic acid; Vulvic acid; 143-07-7; BRN 1099477; Duodecylic acid; LAU; W261416_ALDRICH; LMFA01010012; L4250_SIGMA; Hydrofol acid 1295 C12H24O2 200.32 CCCCCCCCCCCC(=O)O
TCMBANKIN000531 Acetyl-m-xylene 2′,4′-Dimethylacetophenone; 38871_FLUKA; NSC15333; Ethanone, 1-(2,4-dimethylphenyl)-; 2,4-Dimethylacetophenone; FEMA No. 2387; EINECS 201-935-9; AI3-20801; 1-(2,4-DIMETHYLPHENYL)ETHANONE; Acetophenone, 2',4'-dimethyl- (8CI); Acetophenone, 2',4'-dimethyl-; ST5331351; W238708_ALDRICH; ZINC01706892; 2',4'-Dimethylacetophenone; 89-74-7; Methyl 2,4-dimethylphenyl ketone; NSC 15333; D138207_ALDRICH C10H12O 148.2 CC1=CC(=C(C=C1)C(=O)C)C
TCMBANKIN001029 Penconazol C13H15Cl2N3 284.18
TCMBANKIN001349 C09704 ZINC01531550; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (3S,6E)-; EINECS 214-276-7; (3S)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (S-(E))-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; (3S,6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; 1119-38-6; LMPR01030037 C15H26O 222.37 CC(=CCCC(=CCCC(C)(C=C)O)C)C
TCMBANKIN002483 isoincensole,acetate 334.55
TCMBANKIN002724 Butyl octanoate NSC 23740; caprylic acid butyl ester; octanoic acid butyl ester; 589-75-3; Caprylic acid n-butyl ester; NSC23740; Octanoic acid, butyl ester; n-Butylcaprylate; AI3-30983; EINECS 209-659-0; Butyl caprylate C12H24O2 200.32 CCCCCCCC(=O)OCCCC
TCMBANKIN002787 (S)-(+)-alpha-Phellandrene C11391; (5S)-2-methyl-5-propan-2-yl-cyclohexa-1,3-diene; (5S)-5-isopropyl-2-methyl-cyclohexa-1,3-diene; (5S)-5-isopropyl-2-methylcyclohexa-1,3-diene; 2243-33-6; (5S)-2-methyl-5-propan-2-ylcyclohexa-1,3-diene C10H16 136.23 CC1=CCC(C=C1)C(C)C
TCMBANKIN004010 polysaccharide ii
TCMBANKIN004040 myrtenic acid Myrtenate; myrtenicacid; 6,6-Dimethyl-2-norpinene-2-carboxylate; 6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate C14H28O2 228.37 CC1(C2CC=C(C1C2)C(=O)[O-])C
TCMBANKIN004515 cis-resveratrol 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]resorcinol; CHEBI:36002; Tocris-1418; NCGC00024003-02; NCGC00015894-01; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CAS-501-36-0; NCGC00015894-02; NCGC00017352-01; Lopac-R-5010; TNP00294 C14H12O3 228.24 C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
TCMBANKIN005269 Rystal 3-(Acetylamino)-1-hydroxybenzene; 3'-Hydroxyacetanilide; BS 749; Acetanilide, 3'-hydroxy-; 3-Acetamidophenol; N-(3-Hydroxyphenyl)acetamide; Metacetamolum [INN-Latin]; RH 01842; SpecPlus_000775; SPECTRUM211175; NCGC00091423-01; EINECS 210-687-0; CCRIS 4567; NCGC00091423-03; m-Hydroxyacetanilide; BSPBio_002824; Spectrum5_000701; ZINC00001691; 00350_FLUKA; NSC3990; NSC 3990; DivK1c_006871; KBioSS_001456; 3-Hydroxyacetanilide; 3-(Acetylamino)phenol; Spectrum4_000086; 621-42-1; A7205_ALDRICH; NCGC00091423-02; N-(3-hydroxyphenyl)ethanamide; Metalid; BS 479; KBio1_001815; Spectrum_000976; Pedituss; Metacetamol; Metacetamol [BAN:INN]; Acetamide, N-(3-hydroxyphenyl)-; KBio2_004024; Pyrapap; KBio2_006592; m-(Acetylamino)phenol; KBio2_001456; InChI=1/C8H9NO2/c1-6(10)9-7-3-2-4-8(11)5-7/h2-5,11H,1H3,(H,9,10; Spectrum2_000517; SPBio_000473; AI3-01929; BRN 0907998; N-Acetyl-m-aminophenol; KBioGR_000352; Metacetamolo [DCIT]; Spectrum3_001262; m-Acetamidophenol; KBio3_002324 C8H9NO2 151.16 CC(=O)NC1=CC(=CC=C1)O
TCMBANKIN006777 menthiafolin [5-ethenyl-4a,5-dimethyl-1-oxo-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,6-dihydro-3H-pyrano[3,4-c]pyran-3-yl] (2E)-6-hydroxy-2,6-dimethylocta-2,7-dienoate; AC1NSXZ4 C26H36O12 540.6 g/mol CC(=CCCC(C)(C=C)O)C(=O)OC1CC2C(C(OC=C2C(=O)O1)OC3C(C(C(C(O3)CO)O)O)O)C=C
TCMBANKIN007072 80-57-9 Bicyclo(3.1.1)hept-3-en-2-one, 4,6,6-trimethyl-; (1R,5R)-2,7,7-trimethylbicyclo[3.1.1]hept-2-en-4-one; (1R,5R)-2,7,7-trimethyl-4-bicyclo[3.1.1]hept-2-enone; EINECS 201-292-4; EPA Pesticide Chemical Code 128986; 4,6,6-Trimethylbicyclo(3.1.1)hept-3-en-2-one; NCGC00142604-01; ZINC00967600; AI3-23127 C10H14O 150.22 CC1=CC(=O)C2CC1C2(C)C
TCMBANKIN007076 amaroid
TCMBANKIN007207 olibanumol,j 460.82
TCMBANKIN007355 beta-boswellic,acid C30H48O3 456.7
TCMBANKIN007442 p-menth-4-en-3-one AN-19961; 5-Methyl-2-(1-methylethyl)-2-cyclohexen-1-one; 2-isopropyl-5-methyl-cyclohex-2-en-1-one; 5-methyl-2-propan-2-ylcyclohex-2-en-1-one; 2-Isopropyl-5-methyl-2-cyclohexen-1-one #; p-Menth-4-en-3-one; AC1L321A; 5-methyl-2-propan-2-yl-cyclohex-2-en-1-one; 5-methyl-2-isopropyl-2-cyclohexen1-one; SCHEMBL6360973; 2-isopropyl-5-methylcyclohex-2-enone; OAYBZGPDRAMDNF-UHFFFAOYSA-N; AC1Q6CEV; CTK1H2606; 5113-66-6; 2-Cyclohexen-1-one, 5-methyl-2-(1-methylethyl)- C10H16O 152.23 CC1CC=C(C(=O)C1)C(C)C
TCMBANKIN007618 (1R,5R)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane (1R,5R)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1R,5R)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane; BB_NC-1492; (1R,5R)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane C10H16 136.23 CC(C)C12CCC(=C)C1C2
TCMBANKIN007712 olibanumol,i 428.77
TCMBANKIN008157 cembrene,a C20H32 272.47
TCMBANKIN008305 (+)-3-α-hydroxylupanine
TCMBANKIN009095 O-acetyl-β-boswellic acid 498.82
TCMBANKIN010573 incensole,acetate C22H36O3 348.52
TCMBANKIN011588 (1S,3S,5R)-3,6,6-trimethylnorpinan-2-one (1S,3S,5R)-3,6,6-trimethyl-2-norpinanone; (1R,3S,5S)-3,7,7-trimethylbicyclo[3.1.1]heptan-4-one 152.26
TCMBANKIN011753 9-C-Retinal 4-07-00-01254 (Beilstein Handbook Reference); 9-cis-Retinal; (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenal; 9-cis-Retinaldehyde; 9-cis-Vitamin A aldehyde; BRN 1914180; Isoretinene A; 69686-70-0; 514-85-2; 9-cis-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenal; Retinal, 9-cis-; EINECS 208-188-8; LMPR01090017 C20H28O 284.44 CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=O)C)C
TCMBANKIN012523 acetyl-alpha-boswellic,acid C32H50O4 498.74
TCMBANKIN013008 isopropylidenecyclohexane Cyclohexane, (1-methylethylidene)-; Cyclohexane, isopropylidene-; propan-2-ylidenecyclohexane; 5749-72-4 C9H16 124.22 CC(=C1CCCCC1)C
TCMBANKIN013439 insensole oxide CC1=CCCC2(C(O2)CC3(CCC(O3)(C(CC1)O)C)C(C)C)C
TCMBANKIN013861 (3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid (3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-3-hydroxy-14-keto-4,6a,6b,8a,11,12,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid C30H46O4 470.68
TCMBANKIN014101 olibanumol,b 170.28
TCMBANKIN014613 trans-Sobrerol (1S,5R)-5-(1-hydroxy-1-methyl-ethyl)-2-methyl-cyclohex-2-en-1-ol; p-Menth-6-en-2,8-diol, trans; (1S,5R)-5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol; (1S,5R)-5-(1-hydroxy-1-methylethyl)-2-methyl-1-cyclohex-2-enol; ZINC00407097; (1S,5R)-5-(2-hydroxypropan-2-yl)-2-methyl-cyclohex-2-en-1-ol C10H18O2 170.25 CC1=CCC(CC1O)C(C)(C)O
TCMBANKIN015220 (6R)-6-isopropyl-3-methyl-1-cyclohex-2-enone 2-Cyclohexen-1-one, 3-methyl-6-(1-methylethyl)-, (6R)-; (R)-6-(Isopropyl)-3-methylcyclohex-2-en-1-one; EINECS 224-957-0; (6R)-6-isopropyl-3-methyl-cyclohex-2-en-1-one; (6R)-3-methyl-6-propan-2-ylcyclohex-2-en-1-one; 4573-50-6; (6R)-3-methyl-6-propan-2-yl-cyclohex-2-en-1-one C10H16O 152.23 CC1=CC(=O)C(CC1)C(C)C
TCMBANKIN016051 cembrene,c 272.52
TCMBANKIN016328 Estan Androst-4-en-3-one, 17.beta.-hydroxy-17-methyl-; 17.alpha.-Methyltestosterone; 69240_FLUKA; SMR000058528; Premarin with Methyltestosterone; Androst-4-en-3-one, 17beta-hydroxy-17-methyl-; Androst-4-en-3-one, 17-beta-hydroxy-17-methyl-; Methyltestosterone; Dianabol; Homandren (VAN); U 2842; Dumogran; Methyltestosteronum [INN-Latin]; Metandren; Androsan; 17-beta-Hydroxy-17-methylandrost-4-en-3-one; NSC9701; ZINC03814422; Syndren; Homandren, tablets; Synandrotabs; 17-Hydroxy-17-methyl-3-keto-androstene-4; Neo-Hombreol [M]; Malogen; component of Gynetone; 17alpha-Methyl-3-oxo-4-androsten-17beta-ol; METHYL TESTOSTERONE; component of Estan; EINECS 200-366-3; RU 24400; Androsan, tablets; Testred; 4-08-00-01010 (Beilstein Handbook Reference); 46444_RIEDEL; Stenolon; Testoviron (VAN); Methyltestosterone [USAN:BAN:INN:JAN]; Malestrone; 17(alpha)-Methyl-delta4-androsten-17(beta)-ol-3-one; Testoviron; Testoviron (tablet); 4-Androstene-17-alpha-methyl-17-beta-ol-3-one; Androsan (tablets); Mesterone; 1300-17-0; BRN 2057425; Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)-; Neo-Hombreol-M; Oreton Methyl; Homandren; Synandrets; 69241_FLUKA; Neo-Homobreol [M]; Orchisterone-M; Metiltestosterona [INN-Spanish]; 4-Androstene-17alpha-methyl-17beta-ol-3-one; CDB 110; Testred (TN); M7252_SIGMA; Anertan; Metiltestosterone [DCIT]; Anertan (tablets); CCRIS 3723; WLN: L E5 B666 OV MUTJ A E FQ F -B&AEF; Testovis (tablet); M.T.Mucorettes; Glosso sterandryl; 4-Androstene-17.alpha.-methyl-17.beta.-ol-3-one; Oreton-M; NSC 139965; 17alpha-Methyl-4-androsten-17beta-ol-3-one; Android (TN); D00408; Testora; NCGC00091009-01; Androst-4-en-3-one, 17-hydroxy-17-methyl-, (17.beta.)-; (17beta)-17-hydroxy-17-methylandrost-4-en-3-one; 17alpha-Methyltestosterone; 17beta-Hydroxy-17-methylandrost-4-en-3-one; Mastestona; Steronyl; Androsan (VAN); 31745-24-1; Metestone; Android; LMST02020029; Andrometh; Testovis Depot; Methyltestosterone (JP15/USP/INN); 17beta-Hydroxy-17alpha-methyl-4-androsten-3-one; C07198; Nu-man; 17.alpha.-Methyl-3-oxo-4-androsten-17.beta.-ol; Oraviron; component of Tylosterone; Anertan, tablets; Estratest; (17-beta)-17-Hydroxy-17-methylandrost-4-en-3-one; Nabolin; 17-Methyltestosteron; NSC-9701; Hormale; NCGC00091009-03; 17alpha-Methyl-delta-androsten-17beta-ol-3-one; NSC139965; Glosso-Sterandryl; L 589.372; HSDB 3365; Testosterone, 17-methyl-; Anertan (VAN); 17-Methyltestosterone; Masenone; Metrone; 58-18-4; MLS000759474; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; Androsten; Oreton M; Testhormone C20H30O2 302.45 CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C
TCMBANKIN017190 amantadine C10H17N 151.25 g/mol C1C2CC3CC1CC(C2)(C3)N
TCMBANKIN017510 acetyl-beta-boswellic,acid 498.82
TCMBANKIN018028 α-campholenaldehyde 150.29
TCMBANKIN018158 TES ZINC03814409; AA 2500; Geno-cristaux Gremy; Testogel; 17beta-Hydroxy-delta(sup4)-androsten-3-one; Testandrone; NSC 9700; Testosterone and its esters; Testoderm; 4-androstene-17beta-ol-3-one; Androgel (TN); Striant (TN); Andrusol; Cristerona T; CCRIS 574; 58-22-0; Perandren; Synandrol F; Androlin; HSDB 3398; BB_NC-0117; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; Testim; Orquisteron; Androst-4-en-3-one, 17-beta-hydroxy-; Androst-4-en-3-one, 17-hydroxy-, (17-beta)-; Testopropon; CHEBI:17347; Androst-4-en-3-one, 17-hydroxy, (17.beta.)-; AIDS-070519; COL 1621; delta4-Androsten-17beta-ol-3-one; Halotensin; Testosterone [Androgenic steroids, anabolic]; Virosterone; Teslen; Primotest; delta4-androsten-17b-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; Testoject-50; Sustason 250; Androst-4-en-3-one, 17-hydroxy-, (17beta)-; CP 601B; Testosteroid; Malogen, aquaspension injection; Testro AQ; Andropatch; Testosterone (JAN/USP); 17b-hydroxy-4-androsten-3-one; Percutacrine androgenique; Oreton; EINECS 200-370-5; Relibra; 17beta-Hydroxyandrost-4-ene-3-one; Testolin; (17beta)-17-Hydroxyandrost-4-en-3-one; Striant; 4-androsten-17beta-ol-3-one; Virilon; 17-Hydroxy-(17-beta)-androst-4-en-3-one; Testosteronum [INN-Latin]; Testosterona [INN-Spanish]; CDB 111C; 46923_RIEDEL; Testostosterone; 17-Hydroxy-(17beta)-androst-4-en-3-one; Testosterone; LibiGel; 9-beta,10-alpha-ANDROST-4-EN-3-ONE, 17-beta-HYDROXY-; Androst-4-en-17beta-ol-3-one; NCGC00091018-01; D00075; delta(sup 4)-Androsten-17(beta)-ol-3-one; T1500_SIGMA; Testim (TN); Mertestate; trans-Testosterone; Testrone; Testosterone [BAN:INN]; S00309; C00535; Malestrone (amps); Testosterone hydrate; Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one; Androderm (TN); Testiculosterone; 17beta-Hydroxy-4-androsten-3-one; LMST02020002; Primoteston; Sustanone; Neo-testis; Androst-4-en-3-one, 17beta-hydroxy-; beta testosterone; Testoviron Schering; Andronaq; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; Oreton-F; DEA No. 4000; CMC_13449; Androderm; Cristerone T; c1014; 17beta-Hydroxy-3-oxo-4-androstene; AndroGel; 17beta-Hydroxyandrost-4-en-3-one; Testryl; T5411_SIGMA; Homosteron; Testosteron; Testobase; Andro 100; Virormone; Testosterone solution; Homosterone; Testoviron T; AIDS070519; Malerone C19H28O2 288.42 CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
TCMBANKIN019862 (1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-1-cyclohexanol (1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol; (1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; (1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexan-1-ol C28H44O 396.65
TCMBANKIN020121 bassorin CC(C)NC1=NC(=NC(=N1)N=[N+]=[N-])SC
TCMBANKIN022021 acetyl-11-keto-beta-boswellic,acid C32H48O5 512.72
TCMBANKIN022057 podophyllotoxin Spectrum5_001368; AIDS002471; Spectrum2_000878; NCGC00022001-05; Prestwick0_000782; BPBio1_000974; RD4-6269; (-)-Podophyllotoxin; SPBio_002823; Spectrum_000199; AIDS-002471; BSPBio_002352; Podophyllotoxin 7; Podophyllinic acid lactone; Podophyllotoxin; KBio2_003247; Wartec; KBio2_000679; Warticon; UPCMLD-DP035:002; Condyline; NCGC00022001-09; DivK1c_000292; 1,3,3a,4,9,9a-Hexahydro-9-hydroxy-6,7-(methylenedioxy)-4-(3',4',5'-trimethoxyphenyl)benz(f)isobenzofuran-3-one; Naphtho[2,3-d]-1,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl-, .gamma.-lactone; Condylox; ST066914; 518-28-5; Condylox (TN); Podofilox (USAN); (5R,5aR,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one; CCRIS 565; Spectrum4_000592; SPBio_000955; Prestwick_1018; 81125_FLUKA; D05529; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5alpha,5abeta,8aalpha,9alpha))-; BCBcMAP01_000165; 5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, [5R-(5.alpha.,5a.beta.,8a.alpha.,9.alpha.)]; ND-1185; SDCCGMLS-0066888.P001; ZINC03861806; KBio2_005815; NCGC00022001-08; Podophyllotoxin (8CI); C10874; NCI60_001981; Podophyllotoxin (BAN); 858447_ALDRICH; SMR000059121; P4405_SIGMA; AI3-50456; Prestwick2_000782; EINECS 208-250-4; Prestwick1_000782; Prestwick3_000782; UPCMLD-DP035:001; NSC 24818; IDI1_000292; KBioGR_001084; B18-5C; KBio1_000292; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.beta.,8a.alpha.,9.alpha.)]-; NSC24818; Podofilox [USAN]; NINDS_000292; (5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofurano[5,6-f][1,3]benzodioxol-8-one; MLS000069495; HSDB 7238; BSPBio_000884; Mayapple isolate; SMP1_000243; Podofilox; KBioSS_000679 C22H22O8 414.41 COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O
TCMBANKIN022126 (S)-p-Mentha-1,8-dien-7-al ST5308426; (S)-4-Isopropenyl-cyclohexene-1-carboxaldehyde; (S)-(−)-Perillaldehyde; ZINC01529472; (−)-Perillaaldehyde; W355704_ALDRICH; 218294_ALDRICH; (4S)-4-isopropenylcyclohexene-1-carbaldehyde; (4S)-4-isopropenyl-1-cyclohexenecarboxaldehyde; InChI=1/C10H14O/c1-8(2)10-5-3-9(7-11)4-6-10/h3,7,10H,1,4-6H2,2H; (4S)-4-prop-1-en-2-ylcyclohexene-1-carbaldehyde; 77302_FLUKA C10H14O 150.22 CC(=C)C1CCC(=CC1)C=O
TCMBANKIN022314 incensole,oxide C20H34O3 322.48
TCMBANKIN022472 olibanumol,h 458.85
TCMBANKIN023810 7-TETRADECENE 10374-74-0; trans-7-Tetradecene; Tetradec-7-ene; 41446-63-3; 7-Tetradecene,c&t; SBB008954; 7-Tetradecene, (E)-; (E)-tetradec-7-ene; (7E)-7-Tetradecene; 227560_ALDRICH; EINECS 233-815-7 C14H28 196.37 CCCCCCC=CCCCCCC
TCMBANKIN023901 α-boswellicacid CTK8G3918; DTXSID60590811; α-boswellic acid; I07-0238; alpha-boswellic acid; AKOS015896778; (5xi,9xi,10xi)-3-Hydroxyolean-12-en-23-oic acid; AN-45134; 471-66-9; (6aR,6bS,8aR,12aR)-3-hydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid C30H48O3 456.7 g/mol CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1)C)C)C
TCMBANKIN024004 olibanumol,a 186.28
TCMBANKIN024132 (4aR,5S,8R,8aR)-8-hydroxy-5-isopropyl-3,8-dimethyl-1,4a,5,6,7,8a-hexahydronaphthalen-2-one (4aR,5S,8R,8aR)-8-hydroxy-3,8-dimethyl-5-propan-2-yl-1,4a,5,6,7,8a-hexahydronaphthalen-2-one C15H24O2 236.35
TCMBANKIN024359 linalyl butyrate C14H24O2 224.34 CCCC(=O)OC(C)(CCC=C(C)C)C=C
TCMBANKIN025085 (S)-2,2,3-Trimethylcyclopent-3-ene-1-acetaldehyde ZINC01063073; EINECS 245-846-3; 23727-15-3; 2-[(1S)-2,2,3-trimethyl-1-cyclopent-3-enyl]acetaldehyde; 2-[(1S)-2,2,3-trimethyl-1-cyclopent-3-enyl]ethanal C10H16O 152.23 CC1=CCC(C1(C)C)CC=O
TCMBANKIN026031 cis-5-Hydroxy-p-menth-1(6)-en-2-one (4S,5R)-4-hydroxy-5-isopropyl-2-methyl-1-cyclohex-2-enone; (4S,5R)-4-hydroxy-2-methyl-5-propan-2-yl-cyclohex-2-en-1-one; (4S,5R)-4-hydroxy-5-isopropyl-2-methyl-cyclohex-2-en-1-one; (4S,5R)-4-hydroxy-2-methyl-5-propan-2-ylcyclohex-2-en-1-one C10H16O2 168.23 g/mol CC1=CC(C(CC1=O)C(C)C)O
TCMBANKIN026295 dihydroroburic acid 442.8
TCMBANKIN027287 polysaccharide i
TCMBANKIN028893 viridifloro
TCMBANKIN029509 D-arabinonic acid (2S,3R,4R)-2,3,4,5-tetrahydroxyvaleric acid; CHEBI:20912; (2S,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid C5H10O6 166.13 g/mol C(C(C(C(C(=O)O)O)O)O)O
TCMBANKIN029642 3-oxo-tirucallic,acid 454.76
TCMBANKIN029725 (1R,3S)-1-isopropyl-4-methylcyclohex-4-ene-1,3-diol (1R,3S)-4-methyl-1-propan-2-ylcyclohex-4-ene-1,3-diol; (1R,3S)-4-methyl-1-propan-2-yl-cyclohex-4-ene-1,3-diol; (1R,3S)-1-isopropyl-4-methyl-cyclohex-4-ene-1,3-diol 170.28
TCMBANKIN030393 3,6,6-trimethylundecyl-2,5,10-trione 239.37
TCMBANKIN031517 isoincensole,oxide C20H34O3 322.48
TCMBANKIN031915 insensole
TCMBANKIN033547 Medilla BRN 0142217; 7-Hydroxy-4-methyl-2-oxo-2H-1-benzopyran; NCGC00016345-01; Cholonerton; 7-hydroxy-4-methyl-coumarin; Prestwick2_000901; Hymecromonum [INN-Latin]; CAS-90-33-5; C03081; NCI60_042099; 7-hydroxy-4-methyl-chromen-2-one; AI3-08085; CCRIS 5926; Cholestil; 4-Methylumbelliferon [Czech]; BSPBio_000742; ACon1_002401; Imecromone; NSC9408; NSC 9408; LM-94; Hymecromone [USAN:INN:JAN]; Cumarote-C; 7-Hydroxy-4-methylcoumarin; Hymecromone (JP15/USAN/INN); 7-hydroxy-4-methyl-2-chromenone; Bilicante; M1381_SIGMA; D00170; Omega 127; Bilcolic; 7-hydroxy-4-methyl-2H-chromen-2-one; ZINC00058121; CPD-182; NSC19026; BPBio1_000818; Cantabiline (TN); SPBio_002941; MEGxp0_001898; 2H-1-Benzopyran-2-one, 7-hydroxy-4-methyl-; Crodimon; AIDS-018190; AIDS018190; Eurogale; 4-Methyl-7-hydroxycoumarin; NSC 19026; 4-Methylumbelliferon; SR-01000637483-1; beta-Methylumbelliferone; SMR000471886; Cantabiline; WLN: T66 BOVJ E1 IQ; 4-MU; 2H-1-Benzopyran, 7-hydroxy-4-methyl-2-oxo-; Coumarin 4; Cantabilin; LM 94; Prestwick0_000901; MLS001074671; Himecromona [INN-Spanish]; .beta.-Methylumbelliferone; 4-methylumbelliferone; 56275-29-7; 4-Methyl-umbelliferone; 7-Hydroxy-4-methyl-2H-2-chromenone; CHEBI:17224; Pilot 447; Prestwick1_000901; Maybridge1_002078; 2H-1-Benzopyren-2-one, 7-hydroxy-4-methyl-; 7-hydroxy-4-methylchromen-2-one; 5-18-01-00439 (Beilstein Handbook Reference); nchembio.2007.28-comp4; METHYLUMBELLIFERONE, BETA; Coumarin, 7-hydroxy-4-methyl-; Hymecromon; Hymecromone; 69580_FLUKA; EINECS 201-986-7; Imecromone [DCIT]; SBB009085; Prestwick3_000901; Mendiaxon; 90-33-5 C10H8O3 176.17 CC1=CC(=O)OC2=C1C=CC(=C2)O
TCMBANKIN033626 lup-20(29)-ene-3α-acetoxy-24-oicacid
TCMBANKIN034799 arabic acid D-Arabonic acid; 2E716807-8A6D-4F87-9367-F672358A801B; D-Arabonate; 4-03-00-01205 (Beilstein Handbook Reference); NCIOpen2_000178; ARABINIC ACID; AC1Q5SR9; J98.583J; SCHEMBL595388; BRN 1724262; CHEBI:6268; D-D-Arabonate; LS-21521; ARABINONIC ACID, D-; AC1L1UTZ; 2,3,4,5-tetrahydroxypentanoic acid; bmse000166; ARABONIC ACID, K SALT; pentonic acid C5H10O6 166.13 g/mol C(C(C(C(C(=O)O)O)O)O)O
TCMBANKIN035064 olibanumol,c C10H18O2 170.25
TCMBANKIN035160 O-acetyl-α-boswellic acid 498.82
TCMBANKIN035368 (1S,5R)-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enecarboxaldehyde ZINC00968031; InChI=1/C10H14O/c1-10(2)8-4-3-7(6-11)9(10)5-8/h3,6,8-9H,4-5H2,1-2H; (1S,5R)-7,7-dimethylbicyclo[3.1.1]hept-3-ene-4-carbaldehyde; ST5308423 C10H16O 152.23
TCMBANKIN035396 3-hydroxy-tirucallic,acid 426.8
TCMBANKIN035452 olibanore-sene
TCMBANKIN035926 epilupeol acetate C32H52O2 468.75 CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)C
TCMBANKIN036350 1-acetyl-4-isopropenylcyclopentene 1-acetyl-4-isopropenyl cyclopentene C10H14O 150.22 CC(=C)C1CC=C(C1)C(=O)C
TCMBANKIN036814 β-Amyrin SCHEMBL14226156; beta-Amyrine; β- amyrin; beta-amyrin ; beta-amyrin; 12-oleanex-3beta-ol; NSC-527971 426.72
TCMBANKIN036829 ursolic acid ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 C30H48O3 456.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-]
TCMBANKIN036832 daidzein 486-66-8; AIDS-059333; ST057515; KBio2_005871; CCRIS 7600; 7-Hydroxy-3-(4-hydroxy- phenyl)- chromone; SPBio_000205; AIDS059333; 4′,7-Dihydroxy- iso- flavone; nchembio.2007.28-comp31; KBio2_003303; Spectrum3_000191; Isoflavone, 4',7-dihydroxy- (8CI); Oprea1_182317; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; Spectrum5_000857; NCGC00025156-01; BiomolKI_000060; S00273; NCGC00015365-01; KBio1_001023; BiomolKI2_000066; KBioSS_000735; Daidzeol; SMP1_000089; 7,4'-Dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; C10208; SPECTRUM200789; nchembio.76-comp16; BSPBio_001741; NCGC00025156-09; Daidzein (6CI); 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; BRN 0231523; 5-18-04-00089 (Beilstein Handbook Reference); Daidzein; Daidzein (4',7-Dihydroxyisoflavone); KBioGR_002432; NINDS_001023; KBio2_000735; ACon1_000543; NCGC00025156-07; ZINC00047551; daidzein ; NCGC00025156-02; Lopac-D-7802; Tocris-1417; 7-hydroxy-3-(4-hydroxyphenyl)chromone; ACon0_001477; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone; KBio3_001241; DivK1c_001023; Spectrum4_001964; K 251b; UPCMLD-DP052:001; IDI1_001023; MEGxm0_000123; Lopac0_000412; D7802_SIGMA; Spectrum2_000053; EINECS 207-635-4; Spectrum_000255; 4′,7-Dihydroxyisoflavone; NCGC00025156-05; 4',7-Dihydroxy-iso-flavone; NCGC00025156-04; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4-chromenone; 7-Hydroxy-3-(4-hydroxy- phenyl)-4H-1-benzo- pyran-4-one; EU-0100412; CHEBI:28197; SDCCGMLS-0066422.P001; 4',7-Dihydroxyisoflavone; Oprea1_305345 C15H10O4 254.238 c1([H])c(C(=O)C(c2c([H])c([H])c(O[H])c([H])c2[H])=C([H])O3)c3c([H])c(O[H])c1[H]
TCMBANKIN037083 octyl acetate (2S)-2-Ethylhexyl acetate; (2S)-2-Ethylhexyl acetic acid; ZINC1648315; UNII-2C7K8OA8SB component WOYWLLHHWAMFCB-JTQLQIEISA-N; SCHEMBL14625765; octylacetate; AJ-28755; Acetic acid (S)-2-ethylhexyl ester; CJ-05947; CJ-26671; CHEBI:88553 C10H20O2 172.265 C(OC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])(=O)C([H])([H])[H]
TCMBANKIN038707 alpha-amyrin α-Amyrin; C08615; Urs-12-en-3-ol; Urs-12-en-3-ol, (3beta)- (9CI); alpha-Amyrine; Urs-12-en-3.beta.-ol; ST5411384; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-eicosahydro-picen-3-ol; (3.beta.)-Urs-12-en-3-ol; 3-epi-α-amyrin; A834570; Urs-12-en-3-ol #; FSLPMRQHCOLESF-UHFFFAOYSA-N; EINECS 211-352-1; MCULE-7089035597; 12-ursen-3beta-ol; .alpha.-Amyrine; α-amyrin; NSC-114787; alpha-Amyrin; AC1L5E7U; Urs-12-en-3beta-ol; alpha-Amyrenol; Viminalol; 638-95-9; AIDS-070313; Epi-alpha-amyrin; 53017_FLUKA; AIDS070313; AC1Q7B25; .alpha.-Amyrin; 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; NSC 114787; NSC114787; alpha-amyrin ; Urs-12-en-3-ol, (3.beta.)-; .alpha.-Amyrenol; LMPR01060011; α- amyrin; SMP2_000308 C30H50O 426.72 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C
TCMBANKIN038752 p-menth-4-en-1,2-diol 170.28
TCMBANKIN040027 isoincensolol 340.56
TCMBANKIN040186 11-keto-α-amyrenone C30H46O2 438.76 CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1C)C)C
TCMBANKIN040888 p-menth-5-en-1,2-diol 170.28
TCMBANKIN041630 Nopinone (+)-Nopinone; (1R,5S)-6,6-Dimethylbicyclo[3.1.1]heptan-2-one; CJ-29243; (1R,5S)-6,6-dimethyl-Bicyclo[3.1.1]heptan-2-one; (1R)-(+)-Nopinone; AK116367; MolPort-027-835-982; SCHEMBL2388827; 38651-65-9; J-500368; AJ-31006; ZINC1721658; KB-00407; MFCD08447116; Bicyclo[3.1.1]heptan-2-one, 6,6-dimethyl-, (1R,5S)-; Norinone; BG01196965; (1R)-(+)-Nopinone, 98%; AKOS016010310; CHEMBL3782017; XZFDKWMYCUEKSS-BQBZGAKWSA-N; BG01497854 138.21 g/mol
TCMBANKIN041909 isocembrene C20H28 268.436 C(=C([H])[H])(C([H])=C1C(=C(C([H])([H])[H])[C@]2([H])[C@@]([H])(C([H])([H])C(C([H])([H])[H])=C([H])C2([H])[H])[C@@]1([H])C([H])(C([H])([H])[H])C([H])([H])[H])C3([H])[H])C3([H])[H]
TCMBANKIN043830 b-methylaseculetin 192.168 CC1=CC(=O)OC2=CC(=C(C=C12)O)O
TCMBANKIN043853 incensole C20H34O2 306.48 CC1=CCCC(=CCC2(CCC(O2)(C(CC1)O)C)C(C)C)C
TCMBANKIN044229 lup-20(29)-en-3-ol C30H50O 426.72 CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C
TCMBANKIN044693 isofpuquierol 460.82
TCMBANKIN044769 Phellandral EINECS 244-355-1; 21391-98-0; 4-propan-2-ylcyclohexene-1-carbaldehyde; 4-(propan-2-yl)cyclohex-1-ene-1-carbaldehyde; 4-isopropylcyclohex-1-enecarbaldehyde; SCHEMBL220029; 4-ISOPROPYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 4-isopropylcyclohexen-1-aldehyde; ACMC-20lync; AC1L3HZ6; AC1Q6A4A; p-menth-1-en-7-al; AKOS022634915; Phellandral; 4-Isopropylcyclohexenecarbaldehyde; (S)-Phellandral; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethyl)-, (R)-; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethyl)-; 4-[1-Methylethyl]-1-cyclohexene-1-carboxaldehyde; 4-Isopropyl-1-cyclohexene-1-carbaldehyde; AEVLWICMAHGAMS-UHFFFAOYSA-N 152.23 g/mol
TCMBANKIN045065 Tirucallol (3S,5R,10S,13S,14S)-17-((S)-1,5-Dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13S,14S)-17-[(1S)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13S,14S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; AC1LAPT0; Tirucalla-8,24-dien-3 beta-ol 426.72
TCMBANKIN045101 pectolinarin NCGC00179136-01; SPBio_000199; I14-32401; KBioSS_001009; Spectrum2_000210; Spectrum3_000166; KBio3_001131; BG01193545; 5-HYDROXY-6-METHOXY-2-(4-METHOXYPHENYL)-7-{[(2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-({[(2R,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}METHYL)OXAN-2-YL]OXY}CHROMEN-4-ONE; KBio2_003577; SR-05000002766; KBio2_006145; SPECTRUM200115; KBio1_001338; Spectrum4_001489; CCG-38413; 5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; SDCCGMLS-0066414.P001; ZINC3978447; AC1O8FH4; BSPBio_001631; SpecPlus_000298; Spectrum_000529; Spectrum5_000197; 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-; AKOS015909680; KBio2_001009; SR-05000002766-1; 978P021; BRD-K20043699-001-02-3; KBioGR_002097; CHEBI:109534; X1199; Pectolinarin; DivK1c_006394; 28978-02-1 C29H34O15 623 C1(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])=C([H])C(c3c(O1)c([H])c(O[C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[C@]5([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O [H])[C@@]([H])(O[H])[C@@]5([H])O[H])c(OC([H])([H])[H])c3O[H])=O
TCMBANKIN049469 cis-lanceol C15H24O 220.35 CC1=CCC(CC1)C(=C)CCC=C(C)CO
TCMBANKIN049484 phyllocladene C20H32 272.47 CC1(CCCC2(C1CCC34C2CCC(C3)C(=C)C4)C)C
TCMBANKIN058060 gallic acid Spectrum4_001544; NSC-755825; 4CN-0954; KBio2_000822; NCGC00260064-01; KBio3_001168; CHEBI:30778; GTPL5549; D0Y3TZ; NCGC00091125-01; 632XD903SP; ARONIS23903; Spectrum5_000108; Jsp002851; T7419; Gallic acid, puriss., 98.0%; I14-9302; NCGC00091125-07; ZINC1504; 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0); KBioGR_002008; AK-65266; pyrogallol-5-carboxylate; BRD-K77345217-001-01-9; Gallicum acidum; LNTHITQWFMADLM-UHFFFAOYSA-N; KBio2_003390; EBD679760; NCGC00091125-04; AJ-08037; Gallic acid; ZB000350; BG01502846; A808977; (?)-Gallic acid; WLN: QVR CQ DQ EQ; N1830; AC1NEVA5; SBB008781; 149-91-7; GALLIC ACID ANHYDROUS; Gallic acid [NF]; KS-00000IWM; CS-8191; LS-870; C01424; KS-00004784; CHEBI:16918; SPECTRUM210369; c0006; UNII-632XD903SP; ACMC-20aku5; CTK0H5618; BIDD:ER0374; AC1Q732X; NCGC00091125-02; F1908-0156; Oprea1_087792; CG0029; DSSTox_RID_75711; Kyselina 3,4,5-trihydroxybenzoova; 3-10-00-02070 (Beilstein Handbook Reference); RP23206; NSC36997; Gallic acid, certified reference material, TraceCERT(R); AI3-16412; CCG-38670; STK298718; Tox21_202515; bmse000389; AN-15162; AB00052697_03; SR-05000001537-2; NSC-36997; 1886-EP2374526A1; 5-Carboxybenzene-1,2,3-triol; KBio2_005958; SR-05000001537-3; NCGC00091125-05; KBio1_001347; Kyselina gallova [Czech]; KSC175M1R; KBioSS_000822; HMS2091A07; gallate; CPD-183; Spectrum3_000254; 78563C7D-0E2D-4766-A8EA-670A03C78FCF; gallic acid ; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; GDE; SBI-0052184.P002; EINECS 205-749-9; CAS-149-91-7; Kyselina gallova; J3.617.291F; Benzoic acid, 3,4,5-trihydroxy-; BG00601456; DivK1c_006403; Benzoic acid,4,5-trihydroxy-; gallic acid for microelectronic industrial; BRN 2050274; Gallic acid tech.; NCGC00091125-03; Kyselina 3,4,5-trihydroxybenzoova [Czech]; Gallic acid, 97.5-102.5% (titration); gallicacid; 3,4,5-Trihydroxybenzoic acid, anhydrous; NSC674319; TR-020762; 3,4,5-tris(oxidanyl)benzoate; MCULE-1552954312; Gallic acid polymer; Pharmakon1600-00210369; BSPBio_001668; Tox21_111089; HMS1923K07; CCRIS 5523; BDBM50085536; NSC-674319; ST2404570; BB_SC-2795; AC-1206; 3,4,5-trihydroxy-Benzoic acid; Gallic Acid Hydrate; AC1L1934; RTR-020762; GALOP; Q-201146; SR-05000001537-1; DSSTox_CID_650; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; 3,4,5-Trihydroxybenzoic acid ion; GALLICACID; s4603; CHEMBL288114; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; NSC755825; G0011; AB1002218; Gallic Acid, F; MolPort-000-881-260; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; PS-8710; SC-46383; FT-0626592; BBL009937; MFCD00002510; SpecPlus_000307; 3,4,5-trihydroxy-Benzoate; SCHEMBL15012; DSSTox_GSID_20650; ST083487; SR-05000001537; 3,5-Trihydroxybenzoic acid; 3,4,5-Trihydroxybenzoate, X; Tox21_111089_1; Gallic acid (Monohydrate or Anhydrous) (3,4,5-Trih; 3,4,5-Trihydroxybenzoic acid;; Z966690556; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; BC200279; Spectrum2_000399; HY-N0523; HSDB 2117; AC1Q732Y; DTXSID0020650; 5-Trihydroxybenzoic acid; AKOS000119625; NSC 20103; Gallic acid, tech; 138-57-8; NSC-20103; AIDS-001349; gallate; CPD-183; Spectrum3_000254; KBio2_000822; Gallic acid monohydrate; AIDS-059239; KBio3_001168; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; C01424; CHEBI:30778; EINECS 205-749-9; CHEBI:16918; NCGC00091125-01; c0006; J3.617.291F; SPECTRUM210369; Benzoic acid, 3,4,5-trihydroxy-; DivK1c_006403; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; Spectrum5_000108; NCGC00091125-02; BRN 2050274; Oprea1_087792; NCGC00091125-03; 3-10-00-02070 (Beilstein Handbook Reference); SpecPlus_000307; Kyselina 3,4,5-trihydroxybenzoova [Czech]; KBioGR_002008; AI3-16412; NSC674319; pyrogallol-5-carboxylate; 3,4,5-tris(oxidanyl)benzoate; AIDS001349; KBio2_003390; Gallic acid polymer; 1886-EP2374526A1; ZB000350; Gallic acid; BSPBio_001668; KBio2_005958; AIDS059239; CCRIS 5523; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; A808977; 27645_RIEDEL; KBio1_001347; 398225_SIAL; Kyselina gallova [Czech]; WLN: QVR CQ DQ EQ; Spectrum2_000399; HSDB 2117; G7384_SIGMA; KBioSS_000822; GALOP; AC1NEVA5; SBB008781; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; NSC 20103; 3,4,5-Trihydroxybenzoic acid ion; 149-91-7; 3,4,5-trihydroxybenzoic acid; Galllic acid C7H6O5 170.12 C1=C(C=C(C(=C1O)O)O)C(=O)O
TCMBANKIN058213 kaemferol;kampferol;kaempferol;campherol TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- C15H10O6 286.24 g/mol C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O
TCMBANKIN058229 daidzein Daidzei; 486-66-8; AIDS-059333; ST057515; KBio2_005871; CCRIS 7600; 7-Hydroxy-3-(4-hydroxy- phenyl)- chromone; SPBio_000205; AIDS059333; 4′,7-Dihydroxy- iso- flavone; nchembio.2007.28-comp31; KBio2_003303; Spectrum3_000191; Isoflavone, 4',7-dihydroxy- (8CI); Oprea1_182317; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; Spectrum5_000857; NCGC00025156-01; BiomolKI_000060; S00273; NCGC00015365-01; KBio1_001023; BiomolKI2_000066; KBioSS_000735; Daidzeol; SMP1_000089; 7,4'-Dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; C10208; SPECTRUM200789; nchembio.76-comp16; BSPBio_001741; NCGC00025156-09; Daidzein (6CI); 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; BRN 0231523; 5-18-04-00089 (Beilstein Handbook Reference); Daidzein; Daidzein (4',7-Dihydroxyisoflavone); KBioGR_002432; NINDS_001023; KBio2_000735; ACon1_000543; NCGC00025156-07; ZINC00047551; daidzein ; NCGC00025156-02; Lopac-D-7802; Tocris-1417; 7-hydroxy-3-(4-hydroxyphenyl)chromone; ACon0_001477; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone; KBio3_001241; DivK1c_001023; Spectrum4_001964; K 251b; UPCMLD-DP052:001; IDI1_001023; MEGxm0_000123; Lopac0_000412; D7802_SIGMA; Spectrum2_000053; EINECS 207-635-4; Spectrum_000255; 4′,7-Dihydroxyisoflavone; NCGC00025156-05; 4',7-Dihydroxy-iso-flavone; NCGC00025156-04; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4-chromenone; 7-Hydroxy-3-(4-hydroxy- phenyl)-4H-1-benzo- pyran-4-one; EU-0100412; CHEBI:28197; SDCCGMLS-0066422.P001; 4',7-Dihydroxyisoflavone; Oprea1_305345 C15H10O4 254.24 C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O
TCMBANKIN058317 Diphencyprone;2,3-diphenyl-2-cyclopropen-1-one Cyclopropenone, diphenyl- (8CI); CAS-886-38-4; ACMC-20al56; SCHEMBL105663; 2-Cyclopropen-1-one, 2,3-diphenyl- (9CI); SBB059194; MLS000758252; 2,3-diphenyl-cycloprop-2-en-1-one; NSC-57541; VZ22322; GEO-01240; MLS001424007; CHEMBL1373467; RTR-027871; CHEBI:53074; LS-58814; FT-0625256; Cyclopropenone, 2,3-diphenyl-; 4CH-019767; diphenylcycloprop-2-en-1-one; I7G14NW5EC; BBL007727; DSSTox_CID_26545; AKOS005257686; HMS2051I09; CCG-55613; InChI=1/C15H10O/c16-15-13(11-7-3-1-4-8-11)14(15)12-9-5-2-6-10-12/h1-10; TRA0065309; AX8125871; MFCD00001311; PS-4199; 2-Cyclopropen-1-one, 2,3-diphenyl-; 2,3-Diphenylcyclopropenone; D02XXT; Cyclopropenone,3-diphenyl-; 2,3-Diphenylcycloprop-2-en-1-one; KS-00001966; 2,3-Diphenyl-2-cyclopropen-1-one, 99% dry weight, may contain up to 5% water 1g; HMS2231A10; 2-Cyclopropen-1-one,3-diphenyl-; ST24038568; BG01516108; MolPort-001-762-066; AK159241; CPD000449319; AD-310/30361065; AC1L22HV; DPCP; NC00029; SAM001247027; SR-01000644630-1; UNII-I7G14NW5EC; Tox21_112322; SMR000449319; HMS547D03; Diphenylcyclopropenone, purum, >=98.0% (HPLC); OR22091; ZX-AT006360; DSSTox_GSID_46545; Diphenylcyclopropenone, 98%; Diphenylcyclopropenone; Diphencyprone; CTK3J1964; 1,2-Diphenylcyclopropen-3-one; HCIBTBXNLVOFER-UHFFFAOYSA-N; ST50319444; 886-38-4; Tox21_112322_1; KM2694; NSC 57541; EINECS 212-948-4; Epitope ID:113236; Cyclopropenone, diphenyl-; HMS3393I09; MCULE-6674594079; NCGC00166113-01; NSC57541; I14-48040; KB-87826; 2,3-Diphenylcycloprop-2-enone; DSSTox_RID_81708; NCGC00166113-02; Maybridge1_002005; W-200519; 2,3-diphenyl cyclopropenone; 2,3-Diphenyl-2-cyclopropen-1-one; STK289679; DB12173; DTXSID2046545; NCGC00166113-04 C15H10O 206.24 g/mol C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3
TCMBANKIN058761 (E)ocimene (E)- ocimene; (E)-ocimene;p-Ocimene;3,7-Dimethyl-1,3,6-octatriene;trans-ocimene;trans- beta- Ocimene;ocimene;β-trans-ocimene;3,7-dimethyl-1,3e,6-octatriene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;trans-β-Oci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;ci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene C10H16 136.23 g/mol CC(=CCC=C(C)C=C)C
TCMBANKIN058844 Nerol acetate 3, 6-octadienyl acetate; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (2E)-; EINECS 205-459-2; Meraneine; DSSTox_CID_654; Bay pine (oyster) oil; Acetic acid geranyl; 3,7-Dimethyl-2,6-octadienyl acetate; W277304_ALDRICH; Geraniol acetate; 166243_ALDRICH; ST50306944; Jsp000549; 8022-83-1; 130396-84-8; 45896_FLUKA; NSC-72031; trans-3,7-Dimethyl-2,6-octadienyl acetate; 2, 3,7-dimethyl-, acetate,(E)-; HSDB 586; FEMA Number 2509; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (E)-; 68311-13-7; 3,7-Dimethyl-2,6-octadienyl acetate, (Z)-; NSC2584; 3,7-Dimethyl-2,6-octadien-1-yl ethanoate, cis-; (E)-3,7-Dimethyl-2,6-octadien-1-yl acetate; I14-1178; NSC72031; ZX-AT010684; W-108778; (E)-3,7-Dimethylocta-2,6-dien-1-yl acetate; W250902_ALDRICH; AC1LU7NR; BRN 1722814; MLS002152904; 3,7-Dimethyl-2,6-octadien-1-ylacetic acid; GERANYL ACETATE; Geranyl Acetate 98; SCHEMBL56913; HMS2268G10; W250910_ALDRICH; [(2E)-3,7-dimethylocta-2,6-dienyl] acetate; 68412-04-4; 3,7-Dimethyl-2,6-octadien-1-yl acetate, cis-; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate,(E)-; acetic acid [(2E)-3,7-dimethylocta-2,6-dienyl] ester; FEMA No. 2773; 16409-44-2; O310; NCGC00091394-02; 4-02-00-00204 (Beilstein Handbook Reference); 45897_FLUKA; Acetic acid geraniol ester; 130396-85-9; trans-Geraniol acetate; Geranyl acetate, >=97%; trans-3,7-Dimethyl-2,6-octadien-1-ol, acetate; EINECS 203-341-5; acetic acid [(2Z)-3,7-dimethylocta-2,6-dienyl] ester; Acetic acid, geraniol ester; AKOS015837938; 3,7-dimethyl-2,6-octadien-1-yl acetate; 1,6-Octadiene, 7-methyl-3-methylene-, acetylated; Tox21_202089; beta-Geranyl Acetate; WLN: 1Y & U3YU2OV1-T; Geranyl acetate, food grade (71% geranyl acetate, 29% citronellyl acetate); NCGC00259638-01; CCRIS 877; 141-12-8; acetic acid 3,7-dimethylocta-2,6-dienyl ester; Geranyl acetate, analytical standard; Geranyl ethanoate; MolPort-003-855-596; DSSTox_GSID_20654; CHEBI:5331; CHEMBL1369384; NERYLACETATE; 2,6-Octadien-1-ol, 3,7-dimethyl-, 1-acetate, (2E)-; C09861; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, trans-; GERANYL ACETATE FCC; NCGC00254482-01; Linalyl, neryl, geranyl acetates, mixture; AC1Q65TG; cis-3,7-Dimethyl-2,6-octadien-1-ol acetate; 2-02-00-00153 (Beilstein Handbook Reference); 3,7-Dimethyl-2,6-octadien-1-ol acetate; DSSTox_RID_75714; nerylacetate; CJ-24102; Acetic acid, geranyl ester; FEMA No. 2509; [(2Z)-3,7-dimethylocta-2,6-dienyl] ethanoate; 3,7-Dimethyl-2,6-octadien-1-ylacetate; ZINC01531610; DTXSID0020654; 3,7-Dimethyl-2,6-octadienyl acetate, mixture of isomers, >97.0% (sum of isomers, GC); 3,7-Dimethyloctyl acetate, tetradehydro derivative; EC 203-341-5; SCHEMBL56914; CAS-105-87-3; (2Z)-3,7-dimethyl-2,6-octadien-1-yl acetate; Tox21_300355; NCI-C54728; EINECS 240-458-0; Nerol acetate (6CI); Geranyl acetate, natural, FCC; TC-169893; 3,7-Dimethyl-2,6-octadienyl=acetate; ST5306944; 46015_FLUKA; 1-Octanol, 3,7-dimethyl-, 1-acetate, tetradehydro deriv.; EINECS 269-749-0; NSC 2584; Nerol acetate; HIGQPQRQIQDZMP-DHZHZOJOSA-N; (2E)-3,7-Dimethyl-2,6-octadienyl acetate #; 3,7-Dimethyl-2,6-octadien-1-yl ethanoate, trans-; Neryl ethanoate; trans-3,6-octadien-1-ol, acetate; I14-18212; Geranyl acetate, primary pharmaceutical reference standard; 2, 3,7-dimethyl-, acetate, (E)-; CC-35196; MFCD00015037; CHEBI:88568; 3,7-dimethylocta-2,6-dienyl ethanoate; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (2Z)-; 105-87-3; NCGC00091394-03; 3,7-Dimethyl-2-trans, 6-octadienyl acetate; GERANYL ACETATE EXTRA; [(2E)-3,7-dimethylocta-2,6-dienyl] ethanoate; Geranyl acetate (natural); AI3-35817; 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (Z)-; 3,7-dimethylocta-2,6-dien-1-yl acetate; 2, 3,7-dimethyl-, acetate, trans-; ZINC1531610; Geranyl acetate, cis-; Geranyl acetate, FCC; J-007463; Geranyl acetate; 173495_ALDRICH; trans-3,7-Dimethyl-2,6-octadien-1-yl acetate; BDBM50037025; BRN 1722815; 33843-18-4; SMR000127400; 3W81YG7P9R; NCGC00091394-01; trans-2,6-Dimethyl-2,6-octadien-8-yl ethanoate; 3,7-Dimethyl-2E,6-octadienyl acetate; Geranyl acetate A; (2E)-3,7-dimethylocta-2,6-dien-1-yl acetate; 2,6-Dimethyl-2,6-octadiene-8-yl acetate; AN-22398; OR6044; geranylacetat; NCGC00091394-04; Neryl acetate; UNII-3W81YG7P9R; CJ-05234; G0028; Trans-3,7-dimethyl-2,6-octadien-1-yl ethanoate; Geranyl Acetate 60; 1-Octanol, 3,7-dimethyl-, acetate, tetradehydro deriv.; Monoterpene Acetate mixture; NSC-2584; AI3-00207; trans-3,7- dimethyl-2,6-octadien-1-ol acetate; LMFA07010189; Neryl acetate (natural); 3,7-Dimethylocta-2,6-dienyl acetate; cis-3,7-Dimethyl-2,6-octadien-1-yl acetate; [(2Z)-3,7-dimethylocta-2,6-dienyl] acetate; LS-2979; trans-geranyl acetate;nerolacetate C12H20O2 196.29 g/mol CC(=CCCC(=CCOC(=O)C)C)C
TCMBANKIN058851 linalool Spectrum5_000393; KBioGR_002294; KBio2_003260; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; W263516_ALDRICH; ZINC01529820;beta-linalool;NSC-3789; AK-50127; (+/-)-3,7-Dimethyl-1,6-octadien-3-ol; ACMC-209pf1; D0X5DC; Linalool Solution, 1000 mg/L, 1 ml (RM, ISO GUIDE 34); Linalool, primary pharmaceutical reference standard; CDOSHBSSFJOMGT-UHFFFAOYSA-N; AC1L1MRY; Howood Oil; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3S)-; KSC377K8J; AC1Q1NVD; KB-179981; (+/-) LINALOOL; NCGC00259207-01; 3,6-dien-3-ol; AI3-00942; HSDB 645; (S)-Linalol; 2,7-Octadien-6-ol, 2,6-dimethyl-; 2,6-Dimethylocta-2,7-dien-6-ol; Linalool ex orange oil; (?)-3,7-Dimethyl-1,6-octadien-3-ol; DB-062552; I14-13929; FT-0614785; FCH1115719; Tox21_201658; 11024-20-7; BB_NC-00123; MolPort-001-783-101; LS-97796; 2,6-Dimethyl-2,7-octadien-6-ol; Linalool (natural); L0048; Linalool; BRN 1721488; 2,7-octadiene-6-ol; DSSTox_RID_77812; 3,7-Dimethyl-1,6-octadien-3-ol; BC207603; STL373777; AC1Q2BP3; FEMA No. 2635; ANW-37211; MCULE-2407576698; 3,6-octadien-3-ol; Natural Linalool; Linalool b; SCHEMBL20316; BBL027734; EINECS 204-811-2; LINALOOL (+); CU-01000013132-2; LINOLOOL (D); ST069326; dl-3,7-Dimethyl-3-hydroxy-1,6-octadiene; NSC 3789; CHEBI:17580; Linalool ex ho oil; Linalool, 97%; (.+/-.)-Linalool; allo-Ocimenol; GTPL2469; CCRIS 6557; ( -)-Linalool; BG00600803; NCGC00257060-01; C03985; EINECS 201-134-4; HMS2268E18; Tox21_303037; Phantol; (+-)-Linalool; SBB012353; SMR000112394; DTXSID7025502; (R)-3,7-Dimethyl-1,6-octadien-3-ol; DL -3,7-Dimethyl-3-hydroxy-1,6-octadiene; BB_NC-0123; NCGC00091688-04; (+/-)-3,7-Dimethyl-3-hydroxy-1,6-octadiene; CHEMBL25306; MLS002152908; WLN: 1Y1&U3XQ1&1U1 -,-; LINALYL ALCOHOL; Q-201306; 0-01-00-00462 (Beilstein Handbook Reference); SC-74998; CAS-78-70-6; (+/-)-linalool; LINALOOL EX BOIS DE ROSE; RTR-030706; NCGC00091688-02; Linalool, analytical standard; MFCD00008906; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; Linalool, >=97%, FCC, FG; AC-551; Linolool; NSC3789; Linalool, certified reference material, TraceCERT(R); FEMA Number 2635; AKOS015901617; 3,7-Dimethyl-1, 6-octadien-3-ol; p-Linalool; Linalool ex bois de rose oil; FEMA 2635; DSSTox_CID_5502; .beta.-Linalool; EC 201-134-4; TR-030706; CTK2H7584; LS-1752; KS-00000WLW; 3,7-Dimethylocta-1,6-dien-3-ol; DSSTox_GSID_25502; WLN: 1U1XQ1&3UY1&1; 1,6-Octadien-3-ol, 3,7-dimethyl-; ( )-linalool; CCRIS 3726; Linanool; 78-70-6; NCGC00091688-03; Caswell No. 526A; AN-22986; 2,6-Dimethyl-2,7-octadiene-6-ol; (RS)-Linalool; RP21877; (1)-3,7-Dimethyl-1,6-octadien-3-ol; AN-15757; AC1Q1NVE; LINALOOL, (+-)-; NCGC00091688-01; Linalol; beta-Linalool; EINECS 245-083-6; 22564-99-4; Linalool, .beta.; 2,7-dien-6-ol; EPA Pesticide Chemical Code 128838; 1, 3,7-dimethyl-, (-)-; 3,7-dimethyl-octa-1,6-dien-3-ol;L-linalool;CJ-23937; Spectrum5_000393; LMPR0102010013; AKOS028109218; linalool ; Linalool; 1,6-Octadien-3-ol,3,7-dimethyl-, (3R)-; (R)-3,7-Dimethyl-1,6-octadien-3-ol; AC1L9E4Q; KBioGR_002294; (R)-3,7-dimethylocta-1,6-dien-3-ol; KBio2_003260; Epoxydihydrolinalool; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; ZINC1529820; Spectrum4_001777; C11388; linalool oxide; 126-91-0; 3U21E3V8I2; KBio3_002285; CCG-38497; CTK8F1408; KBio2_005828; KBioSS_000692; (-)-Linalool; EINECS 204-811-2; (-)-3,7-dimethyl-1,6-octadien-3-ol; LINALOOL (+); (3R)-Linalool; L-LINALOOL, REF. IND.-14<F128><144><F255>; CHEMBL235672; CHEBI:28; SpecPlus_000909; SCHEMBL891312; (-)-Linalool, analytical standard; UNII-3U21E3V8I2; KBio1_001949; J-005448; MolPort-003-666-060; NCGC00095658-01; FT-0772303; BSPBio_002785; SDCCGMLS-0066889.P001; UNII-D81QY6I88E component CDOSHBSSFJOMGT-JTQLQIEISA-N; L-Linalool; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; L-Linalool, natural, >=95%, FG; SPBio_002007; Spectrum3_001173; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3R)-; NCGC00095658-02; SPECTRUM1501212; SMP2_000331; (-)-Linalool, >=95.0% (sum of enantiomers, GC); Linalool, (-)-; 3R,7-dimethylocta-1,6-dien-3-ol; DivK1c_007005; (R)-linalool; (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol; DTXSID40872607; laevo-linalool; MFCD00135469; Spectrum2_001944; I14-45868; (3R)-3,7-dimethyl-1,6-octadien-3-ol; Spectrum_000212; (R)-(-)-Linalool C10H18O 154.25 g/mol CC(=CCCC(C)(C=C)O)C
TCMBANKIN059023 ()-Bornyl acetate ZINC00388664; ()-Acetic acid bornyl ester; 45853_FLUKA; endo-(1R)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl acetate C12H20O2 196.29 CC(=O)OC1CC2CCC1(C2(C)C)C
TCMBANKIN059178 benzaldehyde,4-(1-methylethyl) P-ISOPROPYLBENZALDEHYDE; 4(2-propyl)-benzaldehyde; NSC-4886; 4-(Methylethyl)benzaldehyde; 4-propan-2-ylbenzaldehyde; 4-isopropylbenzaldehyde; NSC4886; WTWBUQJHJGUZCY-UHFFFAOYSA-N; EINECS 204-516-9; (4-isopropyl-phenyl)-methanone; p-Cuminic aldehyde; AJ-24583; KB-39398; AC1Q1P0K; p-(1-methylethyl)benzaldehyde; ZB015528; InChI=1/C10H12O/c1-8(2)10-5-3-9(7-11)4-6-10/h3-8H,1-2H; ACMC-1BVEJ; Cumal; C06577; NSC 4886; cumaldehyde; MCULE-4415970320; RP21225; SBB040237; ST50213395; DTXSID9021974; Cumin aldehyde; BDBM50139366; SCHEMBL87226; P-isopropyl benzaldehyde; 4-Isopropyl-benzaldehyde; NCGC00257518-01; TR-030618; cuminic aldehyde; NCGC00248148-01; FEMA No. 2341; 4-(isopropyl)benzaldehyde; LS-2642; p-Isopropylbenzenecarboxaldehyde; CJ-04641; Cuminaldehyde, 98%; AI3-01853; 122-03-2; UNII-O0893NC35F; ANW-17932; p-Isopropylbenzaldehyde, f; 4-(Propan-2-Yl)Benzaldehyde; bmse000508; FT-0624115; 4(isopropyl)benzaldehyde; AN-13943; RTR-030618; Cuminal p-(1-methylethyl)benzaldehyde; KSC176K3D; Cuminadlehyde; DSSTox_RID_76435; ST2418438; MolPort-000-871-215; Cuminaldehyde, analytical standard; p-iso-Propylbenzaldehyde; AC1L18ZP; AS-12957; F2190-0632; EC 204-516-9; ZINC968248; 4-iPr-Benzaldehyde; DSSTox_CID_1974; p-cumic aldehyde; DB-041645; I0168; cuminaldehyde; CHEBI:28671; W-108440; CTK0H6531; AC1Q1ONB; AK-44502; 4-isopropyl benzaldehyde; Cuminyl aldehyde; 4isopropylbenzaldehyde; Benzaldehyde, 4-(1-methylethyl)-; 4-Isopropylphenylcarboxaldehyde; p-isopropyl-benzaldehyde; Benzaldehyde, p-isopropyl-; p-isopropyl benzaldehyde; Cuminaldehyde, >=98%, FCC, FG; I01-7253; Cumic aldehyde; O0893NC35F; 4-Isopropylbenzenecarboxylate; 4-07-00-00723 (Beilstein Handbook Reference); CHEMBL161577; AKOS000119738; BRN 0636547; DSSTox_GSID_21974; Tox21_300712; Cuminaldehyd; MFCD00006953; AC-2430; 4-(1-Methylethyl)benzaldehyde; p-isopropyl-Benzaldehyde; cuminal; CAS-122-03-2; WLN: VHR DY1 & 1;FEMA No. 2341; ZB015528; W-108440; CAS-122-03-2; InChI=1/C10H12O/c1-8(2)10-5-3-9(7-11)4-6-10/h3-8H,1-2H; P-ISOPROPYLBENZALDEHYDE; Cumal; C06577; LS-2642; DSSTox_GSID_21974; I01-7253; 4(2-propyl)-benzaldehyde; Cumic aldehyde; TR-030618; EC 204-516-9; Cuminaldehyde, >=98%, FCC, FG; 4-07-00-00723 (Beilstein Handbook Reference); 4(isopropyl)benzaldehyde; DTXSID9021974; CTK0H6531; SCHEMBL87226; KSC176K3D; BRN 0636547; AN-13943; Cumin aldehyde; 122-03-2; P-isopropyl benzaldehyde; MFCD00006953; BDBM50139366; AKOS000119738; p-Isopropylbenzaldehyde, f; AK-44502; p-Isopropylbenzenecarboxaldehyde; AS-12957; EINECS 204-516-9; ZINC968248; Tox21_300712; 4-propan-2-ylbenzaldehyde; cuminic aldehyde; AC1Q1P0K; ST50213395; I0168; CHEMBL161577; NSC-4886; MolPort-000-871-215; p-cumic aldehyde; NCGC00248148-01; 4-iPr-Benzaldehyde; 4-isopropyl benzaldehyde; ACMC-1BVEJ; Cuminaldehyde, 98%; p-(1-methylethyl)benzaldehyde; NSC4886; 4-Isopropyl-benzaldehyde; AJ-24583; Cuminyl aldehyde; 4-isopropylbenzaldehyde; 4-(Methylethyl)benzaldehyde; FT-0624115; MCULE-4415970320; DSSTox_CID_1974; 4-(1-Methylethyl)benzaldehyde; p-isopropyl-Benzaldehyde; Cuminaldehyde, analytical standard; RTR-030618; AC1Q1ONB; F2190-0632; UNII-O0893NC35F; WLN: VHR DY1 & 1; 4-(isopropyl)benzaldehyde; cuminaldehyde; bmse000508; (4-isopropyl-phenyl)-methanone; RP21225; Cuminadlehyde; 4-(Propan-2-Yl)Benzaldehyde; Benzaldehyde, 4-(1-methylethyl)-; ST2418438; WTWBUQJHJGUZCY-UHFFFAOYSA-N; AC-2430; p-iso-Propylbenzaldehyde; Benzaldehyde, p-isopropyl-; 4-Isopropylbenzenecarboxylate; cuminal; NCGC00257518-01; SBB040237; 4-Isopropylphenylcarboxaldehyde; NSC 4886; p-Cuminic aldehyde; KB-39398; AI3-01853; AC1L18ZP; O0893NC35F; Cuminaldehyd; ANW-17932; DSSTox_RID_76435; Cuminal p-(1-methylethyl)benzaldehyde; DB-041645; CHEBI:28671; 4isopropylbenzaldehyde; CJ-04641 C10H12O 148.2 g/mol CC(C)C1=CC=C(C=C1)C=O
TCMBANKIN059521 B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene C10H16 136.23 g/mol CC1(C2CCC(=C)C1C2)C
TCMBANKIN059522 (1R)-()-Nopinone C9H14O 138.21 g/mol CC1(C2CCC(=O)C1C2)C
TCMBANKIN059527 (+)-Camphene C10H16 136.23 g/mol CC1(C2CCC(C2)C1=C)C
TCMBANKIN059531 eucalyptol C10H18O 154.25 g/mol CC1(C2CCC(O1)(CC2)C)C
TCMBANKIN059916 2,6,6-trimethyl-2,4-cycloheptadien-1-one C10H14O 150.22 CC1=CC=CC(CC1=O)(C)C
TCMBANKIN059920 o-methylacetophenone C9H10O 134.17 g/mol CC1=CC=CC=C1C(=O)C
TCMBANKIN059922 o-cresol;Phenol, 2- methyl-;2-hydroxytoluene C7H8O 108.14 g/mol CC1=CC=CC=C1O
TCMBANKIN059974 alpha-phellandrene C10H16 136.23 CC1=CCC(C=C1)C(C)C
TCMBANKIN059982 d-limonene C10H16 136.23 g/mol CC1=CCC(CC1)C(=C)C
TCMBANKIN059985 alpha-terpinol C10H18O 154.25 g/mol CC1=CCC(CC1)C(C)(C)O
TCMBANKIN060024 thunbergol C20H34O 290.48 CC1=CCCC(C=CC(CCC(=CCC1)C)C(C)C)(C)O
TCMBANKIN060372 dl-Thujone C10H16O 152.23 CC1C2CC2(CC1=O)C(C)C
TCMBANKIN060539 α-amyrone C30H48O 424.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1C)C)C
TCMBANKIN060540 Boswellic acid;β一 boswellic acid;β-boswellicacid C30H48O3 456.7 CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C
TCMBANKIN060544 alpha-amyrin C30H50O 426.72 g/mol CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C
TCMBANKIN060593 ()-Aromadendrene;(+)-aromadendrene C15H24 204.35 CC1CCC2C1C3C(C3(C)C)CCC2=C
TCMBANKIN060703 aplotaxene C17H28 232.4 g/mol CCC=CCC=CCC=CCCCCCC=C
TCMBANKIN060971 Satol C18H36O 268.48 g/mol CCCCCCCCC=CCCCCCCCCO
TCMBANKIN061006 lauric acid C12H24O2 200.32 CCCCCCCCCCCC(=O)O
TCMBANKIN061011 1-tridecene; Tridecylene; tridecene C13H26 182.35 CCCCCCCCCCCC=C
TCMBANKIN061058 n-hexadecane C16H34 226.44 g/mol CCCCCCCCCCCCCCCC
TCMBANKIN061072 Glycerol alpha-Monopalmitate C19H38O4 330.5 g/mol CCCCCCCCCCCCCCCC(=O)OCC(CO)O
TCMBANKIN061105 Eicosanoic acid C20H40O2 312.53 g/mol CCCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061174 Tetradecanol C14H30O 214.39 g/mol CCCCCCCCCCCCCCO
TCMBANKIN061177 dodecanol C12H26O 186.33 g/mol CCCCCCCCCCCCO
TCMBANKIN061180 undecyl alcohol C11H24O 172.31 g/mol CCCCCCCCCCCO
TCMBANKIN061183 Decyl acetate C12H24O2 200.32 g/mol CCCCCCCCCCOC(=O)C
TCMBANKIN061187 1-octanol C8H18O 130.23 g/mol CCCCCCCCO
TCMBANKIN061188 Acetate C-8 C10H20O2 172.26 g/mol CCCCCCCCOC(=O)C
TCMBANKIN061335 TBL;thalicarpine NSC 68075; Thalicarpin; NSC-68075; 6a.alpha.-Aporphine, 9-[[4,5-dimethoxy-.alpha.-((S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl]oxy]-1,2,10-trimethoxy-; 4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-1,2,10-trimethoxy-6-methyl-; AIDS-002681; NY IV34 1; 4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S-(R*,R*))-; 4H-Dibenzo[de,g]quinoline, 9-[4,5-dimethoxy-2-[[(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (6aS)-; Taliblastine; (6aS)-9-(2-{[(1S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-4,5-dimethoxyphenoxy)-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline; C09655; STOCK1N-51856; 6aalpha-Aporphine, 9-((4,5-dimethoxy-alpha-(1beta,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl)oxy)-1,2,10-trimethoxy- (8CI); AIDS002681; NSC68075; NCI60_028786; (6aS)-9-(2-{[(1S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-4,5-dimethoxyphenoxy)-1,2,10-trimethoxyaporphine; 4H-Dibenzo[de,g]quinoline, 5,6,6a,7-tetrahydro-9-[4,5-dimethoxy-2-[(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]phenoxy]-1,2,10-trimethoxy-6-methyl-; Thalicarpine; Taliblastin; NY IV-34-1; NY-IV-34-1; 4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S-(R*,R*))- (9CI); 4H-Dibenzo[de,g]quinoline, 9-[4,5-dimethoxy-2-[(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]phenoxy]-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, [S-(R*,R*)]-; En 125-214; Thaliblastine; CHEBI:9509; 5373-42-2; 6a.alpha.-Aporphine, 9-[[4,5-dimethoxy-.alpha.-(1.beta.,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl]oxy]-1,2,10-trimethoxy- C41H48N2O8 696.83 CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC5=CC(=C(C=C5CC6C7=CC(=C(C=C7CCN6C)OC)OC)OC)OC)OC)OC
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab